November 2021 Bonus ASH Annual Meeting Preview Edition

November 2021 Bonus ASH Annual Meeting Preview Edition

Volume 7, Issue 14

This issue offers a behind-the-scenes look at this year’s annual meeting, and more.

Table of Contents

November 2021 Bonus Issue

Idiopathic Multicentric Castleman Disease: Identifying Prevalence and New Treatment Targets

Monday, November 15th, 2021
Two recent studies published in Blood Advances explored idiopathic multicentric Castleman disease (iMCD). Researchers led by Sudipto Mukherjee, MD, MPH, of Cleveland Clinic, provided...

Long-Term Hydroxyurea May Improve Cardiac Abnormalities in Young Patients With Sickle Cell Disease

Monday, November 15th, 2021
Long-term hydroxyurea therapy in children with sickle cell disease (SCD) may reverse cardiac remodeling, according to new research findings. Lead study author Arushi Dhar,...

Intravenously Administered CD19-Directed CAR T Cells Safe, Potentially Effective in Primary CNS Lymphoma

Monday, November 15th, 2021
Intravenously administered CD19-directed chimeric antigen receptor (CAR) T-cell therapy was found to be safe and associated with high levels of complete remission (CR) in...
WIB_icon

How Safe Is Vaccination Against SARS-CoV-2 for Patients With De Novo and Preexisting ITP?

Monday, November 15th, 2021
A report describing the effects of SARS-CoV-2 vaccination on platelet counts of patients with de novo and preexisting immune thrombocytopenia (ITP), including findings of...
WIB_icon

No Difference in CNS Relapse Rates Between IT and IV Prophylaxis Routes in Non-Hodgkin...

Monday, November 15th, 2021
There was no significant difference in central nervous system (CNS) relapse rates between intrathecal (IT) or intravenous (IV) administration routes of prophylaxis administration for...
WIB_icon

BIOIRON Society Recommends New Classification of Hemochromatosis

Monday, November 15th, 2021
During a meeting of clinicians and basic scientists in Heidelberg, Germany, a working group of the International Society for the Study of Iron in...

Evaluating a Machine Learning Approach for the Detection of AML

Monday, November 15th, 2021
Researchers led by Jan-Niklas Eckardt, MD, of the Technical University Dresden in Germany, have developed a machine learning approach that allows for rapid and...

Anemia, Inflammation Associated With Worse Outcomes in Patients With Coronary Artery Disease

Monday, November 15th, 2021
Anemia is strongly associated with immune activation in patients with coronary artery disease (CAD), and a combination of both anemia and increased markers for...

Mycophenolate Mofetil Plus Glucocorticoid Reduces Relapse Risk in ITP

Monday, November 15th, 2021
Initial treatment with mycophenolate mofetil plus a glucocorticoid was associated with a greater response and reduced risk of relapsed or refractory disease compared with...

“Health Equity Tourism” Does More Harm Than Good for Racial Disparities in Medicine

Monday, November 15th, 2021
Following the National Institutes of Health (NIH) announcement that it would provide $100 million in health equity research funding after the COVID-19 pandemic and...

Could an AI Algorithm Diagnose DVT More Efficiently?

Monday, November 15th, 2021
Researchers from the University of Oxford and the University of Sheffield have teamed up with U.K. startup ThinkSono to develop a machine learning artificial...

Female Physicians Face Higher Rates of Infertility and Pregnancy Complications

Monday, November 15th, 2021
As female physicians tend to delay pregnancy until after their residencies, they are more susceptible to fertility issues. Nearly one in four female physicians...

November 2021 Bonus Issue

HPSCs and Hematopoiesis: From Development to Stem Cell Therapies

Monday, November 15th, 2021
As part of this year’s Scientific Program, Gay M. Crooks, MBBS, and Christopher M. Sturgeon, PhD, are co-chairing a session that will review human...

The Future of Iron Therapeutics

Monday, November 15th, 2021
Therapies for disorders of iron metabolism are rapidly progressing beyond venesection, chelation, and nutritional iron supplementation. Recent research elucidating the molecular and structural biology...

Blood and Beyond: Irrigating the Clinical Desert

Monday, November 15th, 2021
This year’s Blood and Beyond session will be hosted by Nancy Berliner, MD, Editor-in-Chief of Blood, and will showcase the work of Paul Farmer, MD,...

The Hematology Laboratory of the Future

Monday, November 15th, 2021
Recent and profound advances in artificial intelligence (AI), data science, and computer vision are having a profound impact on many industries, including medicine. The clinical...

Covering the Full Breadth and Depth of Hematology

Monday, November 15th, 2021
Interview with Education Program co-chairs Alison Loren, MD, and Anita Rajasekhar, MD What were your goals in crafting this year’s education program? Dr. Loren: Dr. Rajasekhar...

Are New Clinical Trial Designs Effective?

Monday, November 15th, 2021
Among the goals of the ASH Subcommittee on Clinical Trials is to increase accrual to clinical trials within the hematology space, ensure diversity among...

The Role of Race in Biomedical Research

Monday, November 15th, 2021
This year’s program includes a “Special Scientific Session on Race and Science” that will feature presentations on the construct of race and the implications...

A Cutting-Edge Program to Contextualize COVID-19

Monday, November 15th, 2021
Interview with Scientific Program Co-Chairs Benjamin Kile, PhD, and Omar Abdel-Wahab, MD As co-chairs, what were your goals in creating this year’s Scientific Program? Dr. Kile:...

November 2021 Bonus Issue

Pulling Back the Curtain: Caitlin Costello, MD

Monday, November 15th, 2021
In this edition, Caitlin Costello, MD, talks about her winding path to a myeloma specialty, and raising four daughters along the way. Where did you...